Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)

By sjmartinez • April 25, 2025

Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV. Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD). Rheumatology (Oxford). 2025 Apr 24:keaf218. doi: 10.1093/rheumatology/keaf218. Epub ahead of print. PMID: 40272902.

Tags: abatacept, anti-synthetase syndrome, Cedars Sinai DoM, Idiopathic inflammatory myopathy, interstitial lung disease, placebo-controlled trial, Publications, Pulmonary, Critical Care & Sleep Medicine, randomized, Rheumatology

Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program

Zhang Y, Nguyen NQH, Hanson PA, Sevilla-Gonzalez M, Haessler J, Sarnowski C, Yao J, Yu B, Jamshidi A, Boerwinkle E, Brown MR, Chen ZZ, Ida[...]

Integrated Strain-Flow Analysis for Early Assessment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Hashemi MS, Falahatpisheh A, Farsiani Y, Matusov Y, Singh S, Ghafourian K, Pedrizzetti G, Kheradvar A. Integrated Strain-Flow Analysis for Early Assessment of Right Ventricular[...]

The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond

Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate[...]